Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

G‐CSF/GM‐CSF‐induced hematopoietic dysregulation in the progression of solid tumors
Kai He, Xi Liu, Robert D. Hoffman, et al.
FEBS Open Bio (2022) Vol. 12, Iss. 7, pp. 1268-1285
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Neutrophils in Cancer immunotherapy: friends or foes?
Xueqin Huang, Eugenie Nepovimová, Vojtěch Adam, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 42
The systemic-level repercussions of cancer-associated inflammation mediators produced in the tumor microenvironment
Dolores Aguilar-Cázares, Rodolfo Chavez-Dominguez, Mario Marroquin-Muciño, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 39
Exploring the JAK/STAT Signaling Pathway in Hepatocellular Carcinoma: Unraveling Signaling Complexity and Therapeutic Implications
Hyun-Jung Park, S.-H. Lee, Jaehun Lee, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 13764-13764
Open Access | Times Cited: 28
Systemic and local immunosuppression in glioblastoma and its prognostic significance
Aleksei A. Stepanenko, Anastasiia O. Sosnovtseva, M. P. Valikhov, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 9
Grade ≥ 3 hematologic adverse events of immunotherapy in advanced NSCLC patients: a systematic review and meta-analysis
Shuang Wang, Meng‐Ting Cai, Yajun Xiong, et al.
European Journal of Clinical Pharmacology (2025)
Closed Access | Times Cited: 1
Integrins in Health and Disease—Suitable Targets for Treatment?
Tanja Klaus, Christoph Hieber, Matthias Bros, et al.
Cells (2024) Vol. 13, Iss. 3, pp. 212-212
Open Access | Times Cited: 4
The role of the hematopoietic stem/progenitor cells-derived extracellular vesicles in hematopoiesis
Ezzatollah Fathi, Behnaz Valipour, Sevda Jafari, et al.
Heliyon (2024) Vol. 10, Iss. 15, pp. e35051-e35051
Open Access | Times Cited: 4
Oncolytic Adenoviruses Armed with Co-Stimulatory Molecules for Cancer Treatment
Aleksander Gryciuk, Marta Rogalska, Joanna Baran, et al.
Cancers (2023) Vol. 15, Iss. 7, pp. 1947-1947
Open Access | Times Cited: 10
Neural crest-associated gene FOXD1 induces an immunosuppressive microenvironment by regulating myeloid-derived suppressor cells in melanoma
Qian Sun, Nina Wang, Juliane Poelchen, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 4, pp. e010352-e010352
Open Access
Asperuloside alleviates cyclophosphamide‐induced myelosuppression by promoting AMPK/mTOR pathway‐mediated autophagy
Hong Che, Linlin Li, Bingjie Zhao, et al.
Journal of Biochemical and Molecular Toxicology (2024) Vol. 38, Iss. 2
Closed Access | Times Cited: 2
High Neutrophil-to-Lymphocyte Ratio Facilitates Cancer Growth—Currently Marketed Drugs Tadalafil, Isotretinoin, Colchicine, and Omega-3 to Reduce It: The TICO Regimen
Richard E. Kast
Cancers (2022) Vol. 14, Iss. 19, pp. 4965-4965
Open Access | Times Cited: 11
Hematologic dysfunction in cancer: Mechanisms, effects on antitumor immunity, and roles in disease progression
Viktoria Plackoska, Dania Shaban, Anastasia Nijnik
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10
Exploring the JAK/STAT Signaling Pathway in Hepatocellular Carcinoma: Unraveling Signaling Complexity and Therapeutic Implications
Hyun-Jung Park, Sang Jik Lee, Jae Hun Lee, et al.
(2023)
Open Access | Times Cited: 5
Immune Evasion of G-CSF and GM-CSF in Lung Cancer
Yeonhee Park, Chaeuk Chung
Tuberculosis & respiratory diseases (2023) Vol. 87, Iss. 1, pp. 22-30
Open Access | Times Cited: 4
Cancer‐associated fibroblast‐derived colony‐stimulating factor 2 confers acquired osimertinib resistance in lung adenocarcinoma via promoting ribosome biosynthesis
Yutang Huang, Xiaoqing Wang, Chunjie Wen, et al.
MedComm (2024) Vol. 5, Iss. 8
Open Access | Times Cited: 1
Decoding the complex web: Cellular and molecular interactions in the lung tumor microenvironment
Bonnie Issa, Ayat Hussein Adhab, Morug Salih Mahdi, et al.
Journal of drug targeting (2024), pp. 1-44
Closed Access | Times Cited: 1
PAK1 overexpression promotes myxofibrosarcoma angiogenesis through STAT5B-mediated CSF2 transactivation: clinical and therapeutic relevance of amplification and nuclear entry
Chien‐Feng Li, Ti‐Chun Chan, Fu‐Min Fang, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 12, pp. 3920-3936
Open Access | Times Cited: 3
Cytokine Immunotherapy for Neuroblastoma
Martin Dowsey
Science Insights (2023) Vol. 42, Iss. 1, pp. 787-792
Open Access | Times Cited: 2
Short-term immune-checkpoint inhibition partially rescues perturbed bone marrow hematopoiesis in mismatch-repair deficient tumors
Paula Krone, Annabell Wolff, Julia Teichmann, et al.
OncoImmunology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 2
Hematopoietic colony-stimulating factors in head and neck cancers: Recent advances and therapeutic challenges
Gustavo de Souza Vieira, Talita de Carvalho Kimura, João Figueira Scarini, et al.
Cytokine (2023) Vol. 173, pp. 156417-156417
Open Access | Times Cited: 1
The association between inflammation-related biomarkers and the subtypes of cancer-related cognitive impairment in colorectal cancer patients: A latent profile analysis
Jun Sun, Yajun Dong, Danhui Wang, et al.
European Journal of Oncology Nursing (2023) Vol. 68, pp. 102493-102493
Closed Access | Times Cited: 1
Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of solid tumors
M Ma, Liang Yao, Meixuan Li, et al.
Cochrane library (2024) Vol. 2024, Iss. 1
Open Access
Expanded tumor-associated polymorphonuclear Myeloid-derived suppressor cells in Waldenstrom macroglobulinemia display immune suppressive activity
Stephen M. Ansell, Vaishali Bhardwaj, Zhi-Zhang Yang, et al.
Research Square (Research Square) (2024)
Open Access
Psychological and physical side effects during G-CSF mobilization in related donors of allo-HCT
Lingxia Cai, Diange Jin, Jianbo Lai, et al.
Annals of Hematology (2024)
Closed Access
Myeloid‑derived suppressor cells as targets of emerging therapies and nanotherapies (Review)
Dileep Kumar, Victor Da Silva, Natália Lemos Chaves
Medicine International (2024) Vol. 4, Iss. 5
Open Access
Page 1 - Next Page

Scroll to top